Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1,414.66%5.17K | -46.60%6.98K | -33.39%4.6K | -25.74%1.41K | -73.80%626 | -81.79%341 | 56.87%13.07K | 186.35%6.9K | -3.55%1.9K | 29.41%2.39K |
| Operating revenue | 1,414.66%5.17K | -46.60%6.98K | -33.39%4.6K | -25.74%1.41K | -73.80%626 | -81.79%341 | 56.87%13.07K | 186.35%6.9K | -3.55%1.9K | 29.41%2.39K |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -29.65%142.72K | -4.35%1.47M | 63.01%724.08K | 28.51%407.22K | -58.73%132.57K | -55.02%202.87K | -33.15%1.53M | -52.44%444.18K | -0.45%316.88K | -42.34%321.25K |
| Selling and administrative expenses | -19.97%124.15K | -0.32%1.25M | 120.11%652.95K | 15.18%347.32K | -70.51%90.87K | -54.89%155.13K | -18.44%1.25M | -40.22%296.64K | 17.12%301.55K | -34.22%308.12K |
| -Selling and marketing expense | 165.68%4.95K | -13.42%18.67K | -57.58%7.44K | 3,219.69%8.43K | 2.87%933 | -34.78%1.86K | -75.56%21.56K | 64.27%17.55K | -95.17%254 | -67.35%907 |
| -General and administrative expense | -22.23%119.2K | -0.09%1.23M | 131.28%645.5K | 12.48%338.89K | -70.73%89.93K | -55.06%153.27K | -14.95%1.23M | -42.52%279.1K | 19.46%301.29K | -34.02%307.22K |
| Research and development costs | ---- | --0 | --0 | --0 | --0 | --0 | -16.33%95.68K | --0 | --0 | --0 |
| Depreciation amortization depletion | ---- | --0 | --0 | --0 | --0 | --0 | -99.14%696 | -98.55%294 | -99.33%135 | -99.35%132 |
| -Depreciation and amortization | ---- | --0 | --0 | --0 | --0 | --0 | -99.14%696 | -98.55%294 | -99.33%135 | -99.35%132 |
| Other operating expenses | -61.09%18.57K | 18.04%220.48K | -51.69%71.13K | 294.14%59.91K | 221.02%41.7K | 320.49%47.74K | -66.98%186.79K | -66.45%147.25K | -62.58%15.2K | -6.72%12.99K |
| Operating profit | 32.08%-137.56K | 3.98%-1.46M | -64.54%-719.48K | -28.84%-405.81K | 58.62%-131.95K | 54.91%-202.53K | 33.48%-1.52M | 53.06%-437.28K | 0.43%-314.98K | 42.57%-318.86K |
| Net non-operating interest income (expenses) | -53.49%-16.41K | -71.97%-73.12K | -281.68%-39.08K | -20.51%-11.86K | 38.62%-11.49K | -187.47%-10.69K | -14.71%-42.52K | -1.35%-10.24K | -0.96%-9.84K | -113.42%-18.72K |
| Non-operating interest expense | 53.49%16.41K | 71.97%73.12K | 281.68%39.08K | 20.51%11.86K | -38.62%11.49K | 187.47%10.69K | 14.71%42.52K | 1.35%10.24K | 0.96%9.84K | 113.42%18.72K |
| Other net income (expenses) | -2,550.73%-14.53K | 322.21%300.2K | 512.97%255.72K | -7,145.16%-11.23K | 90.43%56.26K | -18,166.67%-548 | -53.30%71.1K | -64.76%41.72K | 93.34%-155 | 157.69%29.54K |
| Gain on sale of security | -2,550.73%-14.53K | 39.73%-5.89K | 231.39%12.39K | -7,145.16%-11.23K | -3,527.37%-6.49K | -18,166.67%-548 | -3,714.06%-9.76K | 42.81%-9.43K | 93.34%-155 | 95.13%-179 |
| Special income (charges) | ---- | 508.86%306.08K | 1,084.05%243.33K | --0 | 111.13%62.75K | ---- | 128.47%50.27K | 110.58%20.55K | --0 | 96.28%29.72K |
| -Less:Impairment of capital assets | ---- | --1 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Less:Other special charges | ---- | -424.71%-311.9K | -738.30%-249.15K | ---- | -111.13%-62.75K | ---- | -236.93%-59.44K | ---29.72K | ---- | -96.28%-29.72K |
| -Less:Write off | ---- | -36.58%5.82K | ---- | ---- | ---- | ---- | -72.05%9.17K | ---- | ---- | ---- |
| -Gain on sale of business | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other non-operating income (expenses) | ---- | ---- | ---- | ---- | ---- | ---- | -90.70%30.59K | ---- | ---- | ---- |
| Income before tax | 21.18%-168.5K | 17.36%-1.23M | -23.91%-502.83K | -31.98%-428.9K | 71.70%-87.18K | 52.80%-213.77K | 31.26%-1.49M | 50.70%-405.8K | 1.04%-324.98K | 44.25%-308.04K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 21.18%-168.5K | 17.36%-1.23M | -23.91%-502.83K | -31.98%-428.9K | 71.70%-87.18K | 52.80%-213.77K | 31.26%-1.49M | 50.70%-405.8K | 1.04%-324.98K | 44.25%-308.04K |
| Net income continuous operations | 21.18%-168.5K | 17.36%-1.23M | -23.91%-502.83K | -31.98%-428.9K | 71.70%-87.18K | 52.80%-213.77K | 31.26%-1.49M | 50.70%-405.8K | 1.04%-324.98K | 44.25%-308.04K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 21.18%-168.5K | 17.36%-1.23M | -23.91%-502.83K | -31.98%-428.9K | 71.70%-87.18K | 52.80%-213.77K | 31.26%-1.49M | 50.70%-405.8K | 1.04%-324.98K | 44.25%-308.04K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 21.18%-168.5K | 17.36%-1.23M | -23.91%-502.83K | -31.98%-428.9K | 71.70%-87.18K | 52.80%-213.77K | 31.26%-1.49M | 50.70%-405.8K | 1.04%-324.98K | 44.25%-308.04K |
| Diluted earnings per share | 0 | 0 | 0 | 0 | 0 | 0 | 0.00%-0.01 | -0.01 | 0 | 0 |
| Basic earnings per share | 0 | 0 | 0 | 0 | 0 | 0 | 0.00%-0.01 | -0.01 | 0 | 0 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.